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ABSTRACT
Curtis, Rachael Elizabeth. M.S., Department of Microbiology and
Immunology,
Wright State University, 2011. Distribution of cellular Interferon beta (IFNβ in fibroblasts upon infection of HSV-1.
The hypothesis for this study was: IFN-β expression differs between
murine fibroblasts (A2R1 and L929) of different mouse strains upon
infection of HSV-1. Fluorescent microscopy was used to examine
localization of IFN-β in the different murine fibroblast and keratinocyte cell
lines after 6 hours of infection with herpes simplex virus type-1 (HSV-1).
Because keratinocytes cell lines HEL-30 and PAM-212 grew in clusters,
staining patterns in individual cells could not be determined. A notable
difference in localization of IFN-β immune staining was seen between the
two cell lines when infected with HSV-1. The A2R1 cell line showed
perinuclear (PN) localization, while the L929 cell line showed nuclear
localization suggesting a distinction in response to HSV by these fibroblast
lines. These responses were compared with those stimulated by an inducer
of Type I interferons, polyriboinosinic:polyribocytidylic acid (poly I:C). In
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Poly I:C-treated fibroblasts, cytoplasmic staining was observed at 6 hours
after treatment.
Image J Fire program provided by National Institute of Health (NIH)
was used to determine fluorescent intensities in both the keratinocyte cell
lines and the fibroblast cell lines. The fluorescent intensity was significantly
greater in the L929 fibroblast cell line when treated with poly IC than the
untreated L929 fibroblast. There was no difference in fluorescent
intensities in any of the other cell lines following poly IC treatment.
I attempted to measure IFN-β in the culture supernatants from the
infected cells at different time points: 0, 6, 12 and 24 hours, from all cell
lines (A2R1, L929, Hel-30 and Pam-212) using a Mouse Interferon Beta
ELISA kit (range 15.6 – 1000pg/ml), but none was detected, except for an
insignificant amount in the L929 cells stimulated with Poly IC at 24 hours.
The control standards that were supplied with the kit gave the expected
results.
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INTRODUCTION
On initial infection, a cell responds to a virus by producing Type 1
interferon. There are two subtypes of type 1 interferons: interferon alpha
(IFN- α) and interferon beta (IFN-β). These interferons are released from
infected cells and protect neighboring cells from viral invasion and virus
replication by binding to the Type 1 interferon receptors (IFNARs) located
on the plasma membrane of neighboring cells (Perry et al, 2005).
The amount of interferon produced depends on the cell type and on
the type of pathogen. HSV-1 has been shown to inhibit type 1 interferon
production in certain cell types Perry et al, 2005). In this study, IFN-β
responses produced by several murine fibroblast and keratinocyte cell lines
were investigated. However, with the keratinocyte cell lines, the
localization of IFN-β could not be studied because these cell lines grow in
clumps so accurate cell counts and fluorescent visualization were not
possible and therefore these data sets were omitted from this analysis
(figure 1). There was also not a difference in the mean fluorescent intensity
in the Hel-30 and Pam-212 keratinocyte cell lines (figure 2).
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D - Pam-212 Untreated

Figure 1: Immunostaining of IFN-β in four different cell lines untreated at
a 6 hour time point. Original magnification: 20X. Notice how the
fibroblasts morphology is well defined and separate where with the
keratinocytes, the morphology is not well defined and clumping occurs.
(a) A2R1 fibroblasts; (b) L929 fibroblast; (c) Pam-212keratinocyte; (d)
Hel-30 keratinocyte. Red circles denote where clumping is seen and
individual cells are very difficult to discern.
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Figure 2. Mean Fluorescent Intensity using image J Fire program. Hel-30
and Pam-212 keratinocytes untreated, Poly IC treated and virus infected.
There is no significant difference with the virus infected cells and the poly
IC treated cells compared to the untreated cells.
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C - Hel- Untreated

The hypothesis for this study was: IFN-β expression is different in
murine fibroblasts (A2R1 and L929) derived from different mouse strains
and different from that of keratinocyte cell lines (Hel-30 and Pam-212)
upon infection of HSV-1. To demonstrate potential differences, these
murine cell lines were infected with HSV-1 and then the expression and/or
intracellular localization of interferon-β was determined by
immunofluorescent microscopy. To determine if there were varying
amounts of IFN-β in the culture supernatant fluids, ELISA was used to
quantify IFN-β at 0, 6, 12 and 24 hour time points post infection.
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LITERATURE REVIEW (BACKGROUND)
HSV-1 Infection
HSV-1 is a double stranded DNA virus that can establish both
productive and latent infections and persists in the body for the life of the
carrier by becoming latent in the cell bodies of nerves, where it hides from
the immune system. Reactivated virus can be transported by the nerve
axon to the skin where the virus replicates and causes new sores (Norkin,
2010). HSV-1 infects approximately 60%-80% of the world population and
can lead to ocular herpes, which is one of the major causes of blindness in
the Western world. (Cunningham et al, 2006). HSV-1 promotes a strong
cytokine response in cells that are infected with the virus, stimulates gene
products that interfere with the signaling pathways of type 1 interferons,
and inhibits the synthesis of type 1 interferons. Viruses have developed
successful strategies to overcome the protective effects of interferons
(Peng et al, 2008).
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Epithelial Anatomy
Because the initial site of HSV-1 infection as well as the sites for
lesion formation involves epithelia (skin and mucous membranes)
(figures 3 & 4), it is important to understand the structure of the
epithelial surfaces of the body. The skin offers a barrier of protection
against many environmental factors and from pathogens. The
outermost layer of the skin is the epidermis and is made up of Merkel
cells, keratinocytes, and also contains melanocytes and Langerhans
cells. The epidermis contains five layers: Stratum corneum, Stratum
lucidum, Stratum granulosum, Stratum spinosum and Stratum
germinativum. There are two layers below the epidermis: the dermis
and the hypodermis (figure 5). The dermis is made up of two regions:
the papillary region and the reticular region. The papillary regions
contain loose connective tissue that resembles fingerlike projections
which interact with the epidermis. The reticular region is composed of
dense connective tissue and is also the area that contains the hair roots,
sweat glands, sebaceous glands and blood vessels (Tortora, 2006).
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The hypodermis is not part of the skin and its function is to connect
the skin with the bone and muscle. The dermis and hypodermis both
contain fibroblasts. Fibroblasts are found everywhere within the body
and have long been considered to be essential structural elements of
tissue integrity. Tissue-specific fibroblasts play an important role as
immunoregulatory cells that can mount and influence immune
responses by being able to secrete chemokines and cytokines (Ibelgauft,
2011).
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Figure 3. Illustration of the top layer of the epithelium which is
keratinized and protects against friction and invasion from pathogens.
Adapted from McGraw Hill, 1999.

Figure 4. Illustration of the top layer of the epithelium which is the
non-keratinized type (mucous membrane) found in the oral cavity.
Adapted from McGraw Hill, 1999.
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Figure 5. Illustration of the Layers of skin adapted from Slomianka,
2009.
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Interferon Beta (IFN-β)
Interferons are proteins that are made and released by cells upon
invasion of a pathogen. In humans, there are many different forms
(isotypes) of type I interferon and all of them bind to the same receptor on
the surface of the plasma membrane and are similar in structure. The only
one form of beta interferon in humans also binds to the same IFNAR as the
IFN-α molecules. In contrast to IFN-α, IFN-β of other animal species is
inactive in human cells (Davidson College, 2000).
IFN-β can act in a paracrine or autocrine fashion. The receptor that
is found on the plasma membrane initiates the signal transduction pathway
after binding of IFN-β (figure 6). Once IFN-β has bound to its receptor, the
intracellular domains of IFNAR1 and IFNAR2 chains associate with two
Janus-family tyrosine kinases, JAK1 and Tyk2, which transphosphorylate
each other and phosphorylate the receptors. IFNAR1 and IFNAR2 bind to
STAT1 and STAT2 (signal transducer and activator of transcription1). The
STAT proteins dimerize and move to the nucleus where they activate
specific genes (Peng, 2007).
10

Interferon-β is generally produced by fibroblasts and some epithelial
cell types. (Norkin, Virology p. 85) Interferon-β can be induced by viruses,
double stranded RNA and micro-organisms. It can also be induced by
cytokines such as TNF and IL1. (Ibelgauft, 2011)
Mouse Interferon beta (mu IFN-β) is very rapidly internalized by
receptor-mediated endocytosis and binds to the nuclei of mouse
fibroblasts. The receptors on the nucleus of the fibroblasts are not only
present in a higher affinity than on the plasma membrane, but the
receptors are also more dense on the nuclear membrane than on the
plasma membrane (Kushnaryov et al, 1985 & 1986). Kushnaryov and
collegues also showed that after binding of mu IFN-β to the receptor on the
plasma membrane of mouse L cells, it only took 3 minutes for most of the
IFN-β molecules to reach the nucleus.
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Figure 6. Illustrations of Type 1 interferon receptors (IFNAR1 and IFNAR2)
binding to Interferon beta in the plasma membrane of a cell. Adapted
from Davidson College Department of Biology, Davidson, NC
http://www.bio.davidson.edu/courses/immunology/Students/spring200
0/white/ifnbeta.html

Mechanisms of inducing Interferon Beta
Type 1 interferons are transcriptionally regulated and IRF3
(interferon regulatory factor) primarily regulates production of IFN-β
(Figure 7). (Perry et al, 2005). IRF3 is continually expressed in all cells and is
found in an inactivated state in the cytoplasm of unstimulated cells. (Perry
et al, 2005). Upon stimulation, IRF3 becomes phosphorylated, dimerizes
and translocates into the nucleus and then activates the expression of IFNβ. When IFN-β is produced, it starts a positive feedback loop and acts in an
12

autocrine and paracrine fashion by binding to IFNAR. Once this occurs, the
JAK/STAT pathway is activated and a transcription factor complex
(ISGF3)(IFN-stimulated gene factor 3) translocates into the nucleus and
binds to IFN-stimulated response elements (ISRE) to induce expression of a
large group of IFN-inducible genes. (Perry et al, 2005).
Protein Kinase RNA-activated (PKR) is another signaling pathway in
which interferon is induced. PKR is activated by interferon or double
stranded RNA which is synthesized from infection by a virus. PKR becomes
phosphorylated, which then phosphorylates EIF2A. This phosphorylated
EIF2A then inhibits cellular mRNA translation, and then prevents viral
protein synthesis. Active PKR also induces NFkB by phosphorylating IkB,
which upregulates Interferon beta. L929 cells utilize PKR as a predominant
antiviral, IFN-mediated pathway when infected with HSV-1. (Harle, 2002).
Mechanisms HSV-1 has for evading Induction of Interferon Beta
HSV-1 inhibits the production of IFN-β by the immediate early viral
protein ICP0 and ICP34.5. ICP0 and ICP34.5 inhibit the nuclear
accumulation of IRF-3 and enhance the degradation of activated IRF-3
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which interferes with the pathway of IFN-beta production.(Melroe et al,
2004) and (Johnson et al, 2008).
HSV-1 blocks the signaling effects of type 1 interferons by reversing
the effects of the double-stranded RNA-activated protein kinase (PKR).
HSV-1 also blocks the phosphorylation of STAT1 and STAT2. (Melroe et al,
2004).
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Figure 7. The different pathways that are involved in the activation of
Type 1 interferon production. Adapted from Perry et al, 2005.
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MATERIALS AND METHODS
Cell Culture
L929 cells from C3H mice and A2R1 cells from Balb/C mice are
fibroblasts that populate the dermal layer of the skin. These cell lines were
cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Fisher Scientific,
Pittsburgh, PA) supplemented with 10% heat-inactivated fetal calf serum,
and 1% gentamicin solution (50mg/ml). The cells were grown in 100mm2
tissue culture dishes and incubated in a humidified incubator at a
temperature of 37o C with 5% CO2.
Virus and Cell Infection
HSV-1 (syn-17+) (initially provided by Dr. Nancy Sawtell, Children’s
Hospital Medical Center, Cincinnati, OH) was titrated using Vero Cells (CCL8, American Type Culture Collection). When the cytopathic effect was
evident, the cells and supernatant were harvested and stored in 200ul
aliquots at -80 degrees C. The number of plaque forming units (PFU) were
calculated after performing a plaque assay on Vero cells. All four cells lines
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were plated either on sterile glass coverslips placed in 24 well plates or
directly on 24 well culture plates, depending upon the experiment. The
virus was dispensed at 0.1 MOI in DMEM containing 2% calf serum on the
cell monolayer in the 24 well culture plates when they were about 80%
confluent and then placed in an incubator at 37o C. The virus was left on
the cells for 2 hours and then the culture medium was removed and
replaced with fresh culture medium. Mock infected cells were treated the
same way, except 2% culture medium was used. For the immunostaining,
each cell line was dispensed on glass coverslips that were in 24 well plates
and infected as previously described. The coverslips were removed at the 6
hour time point, which has been shown to be a significant time to see IFN-β
production and immunostaining was performed (Rosztoczy et al, 1986);
(Fujisawa et al, 1997); (Li et al, 2011a).
Immunostaining for IFN-β
At the end of the 6 hour time point, the cells were rinsed once with
room temperature (RT) phosphate buffered saline (PBS) and then the PBS
was removed. 10% Formalin fix which is used to preserve cell morphology
was added and incubated at room temperature (RT) for fifteen minutes.
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The fix was removed and quenched with sodium borohydride that was
prepared just prior to use in PBS. The cells were incubated in this solution
for 15 minutes at RT. The cells were then washed 3 times with PBS. The
cells were then permeabilized with 0.2% Triton-X 100 in PBS for 10 minutes
at RT and then washed again in PBS three times. 3% BSA (Bovine Serum
Albumin) blocking solution was added to the cells and incubated at RT for
30 minutes. The primary mouse IFN-β polyclonal antibody was prepared in
the blocking buffer diluted 1:100 and then it was applied to each coverslip.
The coverslips were placed in a humidified chamber cell side down and
allowed to incubate at 4o C overnight. The coverslips were transferred back
to into their dishes and washed three times with PBS. The secondary
fluorescent-labeled (cyanine 5) anti-mouse IgG, was prepared and applied
to each coverslip as described above and allowed to incubate for 2 hours at
RT in the dark. The coverslips were placed back into their dishes and
washed 3 times with PBS. The coverslips were then mounted onto glass
slides (two on each slide) using liquid mounting media Vectashield (Vector
Labs) and then sealed with clear nail varnish. The slides were then analyzed
by light microscopy. Calibration bars were added to the pictures and were
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saved onto the picture by merging the calibration bar with the picture
before saving them to the computer.
ELISA
Cells were plated onto 24 well culture dishes and infected with virus
as described above. Supernatant was removed from separate wells at
specified time points of 0, 6, 12 and 24 hours post infection and placed at 20o C until samples could be analyzed. Untreated cells were used as the
negative control and cells treated with Poly-IC were used as the positive
control. All four cell lines (Hel-30, PAM-212, L929, A2R1) were used in 3
separate experiments. The assay quantitates mouse interferon beta in
media using a sandwich enzyme immunoassay. The microtiter plate is precoated with IFN-β capture monoclonal antibody to which the samples and
standards are added. The supernatant was then prepared according to the
manufacturers specifications for the ELISA (PBL Biomedical Laboratories,
Piscataway, NJ). The substrate supplied with the kit was TMB which is a
colorimetric substrate for horseradish peroxidase (HRP). The color intensity
is proportional to the amount of HRP activity which is correlated to the
amount of the target protein, in this case, IFN-β. The results were obtained
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by reading the plate on an ELISA Plate Reader at a wavelength of 450 nm.
This ELISA kit has an assay range of 15.6 – 1000pg/ml.
Statistical Analysis
Statistical Analysis was performed using Sigma Plot 12.0. The values
that are expressed are the Standard Error of the Mean (SEM). The HolmSidak method was used to determine the significance between the treated
groups and the control groups.
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RESULTS AND DISCUSSION
Selection of the MOI for transfection of virus in the different cell lines
Different MOI’s were used to determine the appropriate dilution to
use on the cell lines. Cytopathic effects assays were used to determine the
MOI (data not shown) 0.1 MOI was chosen because it had cytopathic
effects on the cells. Data from Frey et al, 2009 were also used as reference
and those results were similar as well.
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IFN-β localization in A2R1 fibroblast in response to HSV-1
A minimum of 100 cells per experiment was counted, all cells per
field were counted with a minimum of 3 fields per experiment and
observed for cytoplasmic fluorescence, nuclear fluorescence, or perinuclear
fluorescence. At least three replicates of each experiment were performed.
The untreated A2R1 cells have nuclear localization of IFN-β. When
infected with the virus, both perinuclear (PN) and cytoplasmic localizations
of IFN-β in response to the virus was observed (figures 8 & 9). These
results suggest that HSV-1 stimulates IFN-β expression/localization. This
analysis supports Frey’s findings that fibroblasts were better protected
from HSV-1 than the keratinocytes following treatment with IFN-y which
synergizes with the innate IFN-β response. When treated with Poly IC,
IFN-β becomes localized primarily in the cytoplasm compared with the
nuclear localization of the untreated cells (figure 8C & 10). This observation
indicates that A2R1 fibroblast cell line was capable of producing IFN-β.
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Figure 8. Fluorescent microscopy of A2R1 fibroblast cells presenting IFN-β
localization. a. Untreated A2R1 fibroblast with nuclear localization of
IFN-β. b. Virus infected A2R1 fibroblast with perinuclear localization of
IFN-β, 6 hr PI. c. Poly IC treated A2R1 fibroblast with cytoplasmic
localization of IFN-β, 6 hr PI.
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Figure 9. Percent localization of fluorescence of interferon beta in the
perinuclear region of A2R1 fibroblasts. The untreated cells were used as a
control. In The virus infected cells, the localization was measured 6 hours
after infection with HSV-1. Difference from control: *p=0.042.
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Figure 10. Percent Localization of fluorescence of Interferon Beta in the
cytoplasm of A2R1 Fibroblasts.
The Untreated cells were used as control. In the virus infected cells, the
localization was measured 6 hours after infection with HSV-1. Difference
from controls: *P<0.001.
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IFN-β localization in L929 fibroblasts in response to HSV-1
After six hours post infection (PI) there was nuclear localization of
IFN-β which was the same as the untreated cells which also showed nuclear
localization of IFN-β. However, upon stimulation with Poly IC, the L929 cells
displayed significant levels of cytoplasmic fluorescence compared with the
untreated cells (figure 11A, 11C & 12); like the A2R1 fibroblasts, this
staining pattern shows that the L929 cells are capable of producing IFN-β.
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Figure 11. Fluorescent microscopy of L929 fibroblast cells presenting IFNβ localization. a. Untreated L929 fibroblast with nuclear localization of
IFN-β. b. Virus infected L929 fibroblast with nuclear localization of IFN-β,
6 hr PI. c. Poly IC treated L929 fibroblast with cytoplasmic localization of
IFN-β, 6 hr PI.
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Figure 12. Percent localization of fluorescence of IFN-β 6 in L929
fibroblasts. The Untreated cells were used as control. In the virus
infected cells, the localization was measured 6 hours after infection with
HSV-1. Difference from controls: *P<0.001.
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Comparison of IFN-β localization in A2R1 fibroblast with L929 fibroblast in
response to HSV-1
Following infection when infected with virus, the A2R1 showed
perinuclear localization while the L929 had nuclear localization (figures 13
& 14). Since L929 cells utilize the PKR as a predominant antiviral pathway
(Harle et al, 2002) and HSV-1 disrupts this pathway by dephosphorylating
PKR (Harle et al, 2002), IFN-β production and secretion is inhibited in the
virus-infected L929 fibroblast.
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Figure 13. Percent localization of fluorescence of interferon beta in the
nucleus and perinucleus (PN) of virus infected A2R1 and L929 fibroblast
cell lines. The difference in % localization is a comparison between the
two cell lines: *P=<0.001.
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Figure 14. Comparison of A2R1 fibroblast with perinuclear localization
and L929 fibroblast with nuclear localization at 6 hours PI.

31

Comparing mean fluorescence between A2R1 fibroblast the L929
fibroblast
The mean fluorescence intensity was measured using Image J Fire
Program to quantify IFN-β expression. At least three fields per group and a
minimum of three experiments performed. The same fields were assessed
using Image J that were used in determining the localization of IFN-β. The
pixel intensity was measured and the mean fluorescent intensity was
calculated using this program.
When the mean fluorescence was measured, there was a significant
difference in the L929 cells treated with poly IC compared with the
untreated L929 cells (figures 15 & 16). However, in the A2R1 fibroblast
cells, the mean fluorescence was about the same as the untreated A2R1
(figures 15 & 16).
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Figure 15. Poly IC treated L929 has significantly more mean fluorescence
than the L929 untreated cell. There is no significant difference in the
mean fluorescence of the A2R1 fibroblast cell line. Difference from
untreated: *p=0.036.
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Figure 16. Mean Fluorescent Intensity using image J Fire program. L929
and A2R1 fibroblasts untreated, Poly IC treated and virus infected. Note
the difference in the untreated L929 cells with the Poly IC treated L929
cells. There is no significant difference between the virus infected cells
and the untreated cells.
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ELISA
I attempted to measure IFN-beta in the culture supernatants from the
infected cells from all four cell lines at different time points: 0, 6, 12 and 24
hours, using a Mouse Interferon Beta ELISA kit (range 15.6 – 1000pg/ml),
but could not detect any IFN-β within this range. A detectable, but
insignificant amount was released by the L929 cells stimulated with Poly IC
at 24 hours. The control standards that were supplied with the kit gave the
expected results. The samples were stored at -80°C with no protease
inhibitors added.
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CONCLUSION AND FUTURE STUDIES
HSV-1 has evolved several successful strategies to overcome the
antiviral state produced by the cell upon infection. A difference in
localization of IFN-β was noted between the A2R1 fibroblast and the L929
fibroblast at 6 hours after infection with HSV-1. A2R1 cells showed
perinuclear fluorescence while the L929 fibroblasts exhibited nuclear
localization. HSV-1 infected L929 cells appeared unresponsive to IFN-β
production in comparison with uninfected L929 cells which also showed
nuclear localization. It is difficult to interpret the nuclear staining for IFN-β
in the infected cells. Since the culture medium contained 10% calf serum,
mitogens in the serum could have stimulated expression of IFN-β. Culturing
the fibroblast cell lines in serum-free medium would address this concern.
Removing serum-induced mitogenicity should reduce or eliminate IFN-β
staining at six hours after infection if the staining was due to serum
mitogens.
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Another aspect of the nuclear staining pattern to be investigated
involves the observation of Kushnaryov et al. (1985 and 1986) that the
nuclear envelope contains a denser distribution as well as higher affinity
receptors for IFN-β than does the plasma membrane of murine fibroblasts.
If the nuclear envelope of mitogen-stimulated fibroblasts were saturated
with IFN-β-receptor interactions, the entire nucleus would appear
fluorescent when the whole cell is observed microscopically. Using confocal
microscopy to optically section the cell should differentiate between
staining of the nuclear envelope and the nucleoplasm. In addition, results
of confocal co-localization experiments using different fluorescent tags for
antibodies to nuclear pore proteins and IFN-β would indicate whether IFN-β
was exiting the nucleus or being synthesized at the nuclear envelope.
Upon stimulation with Poly IC, both fibroblast cell lines display
cytoplasmic fluorescent localization, both of which are significant when
compared to the untreated cells. Perinuclear staining for IFN-β would
suggest successful egress or synthesis and cytoplasmic staining of IFN-β, as
seen in the poly-IC-stimulated cells. This would indicate successful
synthesis of IFN-β and accumulation in the cytoplasm.
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The use of phase-contrast microscopy in conjunction with fluorescent
microscopy would show differences in the numbers of intact cells stained
as opposed to unstained cells. For example, in the Image J Fire analysis
many fewer cells showed fluorescent staining in the virus-infected samples
at six hours after infection, a time at which viral lysis would not have
occurred. The use of phase-contrast microscopy would determine whether
some of the cells had not stained positive for IFN-β.
Frey (2009) noted that L929 fibroblasts were better protected from
HSV-1 than keratinocytes following treatment with IFN- and suggested
that the IFN- synergizes with the innate IFN-β response. He also noted
that IFN-β mRNA transcripts were not enhanced in HSV-1-infected L929
cells over those seen in uninfected cells (Frey, 2009). In a future study, it
would be of interest to determine whether IFN--treated L929 fibroblasts
are able to produce both IFN-β transcripts (as detected by PCR) and protein
(as detected by perinuclear and cytoplasmic localization ) as well as
secreted IFN-β ( as detected in an ELISA assay). The synergistic or additive
anti-viral relationship between IFN- and IFN-β in eliciting a greater IFN-β
response in the A2R1 fibroblast can be measured in a virus plaque assay.
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Greater cell survival and fewer virus plaques should be detected in HSV-1
infected cells pretreated with both IFN-β and IFN- than with either IFN.
Examining the IFN-β response in IFN--treated keratinocyte cell lines
would also be of interest. Frey et al (2009) showed that keratinocytes (HEL30) were refractory to IFN- induction of an antiviral state upon HSV-1
infection. In contrast, IFN- induced an antiviral state in fibroblasts (L929).
This effect in keratinocytes was attributed to the production of suppressor
of cytokine signaling-1 (SOCS-1) which played an important role in the
inhibition of the antiviral effect of IFN- in HSV-1-infected keratinocytes.
Both IFN- and HSV-1 were found to upregulate production of SOCS-1 in
keratinocytes. By comparison, HSV-1 infection exerted minimal to no effect
on induction of SOCS-1 protein in L929 fibroblasts (Frey et al, 2009). It
would be of interest, in future experiments, to determine whether an
inhibitor of SOCS-1 would permit the keratinocyte to display an IFN-β
response and protect the cells from lytic HSV-1 infection similar to that
seen by Frey et al (2009). Ahmed et al (2010) has recently found that SOCS1 inhibitors enhanced the IFN-β levels of L929 fibroblasts following
infection with vaccinia virus or encephalomyocarditis virus . Keratinocytes
treated with an inhibitor of SOCS-1 could be protected by IFN- from HSV-1
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lytic infection (Frey et al, 2009). It might also be worthy to investigate the
role of IFN-α similar to that of IFN-β in these four cell lines using
fluorescently labeled anti-murine IFN-α antibody in immune localization
experiments.
Enhancement of the detection of secreted IFN-β by ELISA could be
improved by: (1) concentrating the tissue culture supernatant fluids before
testing; (2) inclusion of a protease inhibitor in the collected supernatant
fluids to prevent proteolysis of any interferon in the sample;(3) examining
treated cells at an earlier times, e.g. 2 and 4 hours post-treatment or postinfection; and (4) selection of less dilute monoclonal antibody pairs in the
ELISA assays. Ahmed et al (2010) recently noted that L929 fibroblasts
treated with an inhibitor of SOCS-1 protein for 30 and 60 minutes exhibited
increased basal levels of IFN-β which were below 10 pg/ml as measured by
ELISA. Obviously, the ELISA kit used in this study was not sensitive enough
to detect the basal IFN-β levels seen in the immunofluorescence
experiments.
In the innate immune responses to HSV-1 infection, Lopez (1975)
assumed that difference in type I interferon responses (IFN-α/β)
augmented by type II IFN- produced by NK cells in initial infection
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accounted for the differences seen in response by several mouse strains to
intraperitoneal infection with HSV-1. Others have not confirmed these
observations. More recently, Halford and colleagues (2004) re-evaluated
the natural resistance to HSV-1 by some of the same mouse strains and
noted that the individual murine species do not appear to differ in their
innate resistance to HSV-1 infection when considering differences in virus
strains, transmission sites, and conditions. Consequently, little can be
attributed to the differences seen in this study in the IFN-β response to
HSV-1 infection by A2R1 (Balb/c) and L929 (C3H) fibroblasts. The early
interferon responses can only account for host resistance to virus for the
first five to seven days of infection after which the immune response
contributes to viral pathogenesis and resistance (Mercalf and Michaelis,
1984).
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